Showing results (61-70 of 128) with videos related to
Sort By:
Pageof 13
Cardiovascular Drugs and Therapy|November 29, 2011
Pharmacokinetics, pharmacodynamics and safety of tolvaptan, a novel, oral, selective nonpeptide AVP V2-receptor antagonist: results of single- and multiple-dose studies in healthy Japanese male volunteersSeong Ryul Kim, Tomoko Hasunuma, Osamu Sato, et al.Advances in Experimental Medicine and Biology|February 26, 2009
Beneficial effect of taurine treatment against doxorubicin-induced cardiotoxicity in miceTakashi Ito, Satoko Muraoka, Kyoko Takahashi, et al.Plos One|September 18, 2014
Tissue depletion of taurine accelerates skeletal muscle senescence and leads to early death in miceTakashi Ito, Natsumi Yoshikawa, Takaaki Inui, et al.FEBS Letters|July 12, 2005
Platelet activating factor induces cytoskeletal reorganization through Rho family pathway in THP-1 macrophagesChinuyo Sumita, Masako Yamane, Takahisa Matsuda, et al.Biochemical and Biophysical Research Communications|November 30, 2004
N-cadherin-mediated cell adhesion determines the plasticity for cell alignment in response to mechanical stretch in cultured cardiomyocytesTakahisa Matsuda, Kyoko Takahashi, Tetsurou Nariai, et al.Drug Metabolism and Pharmacokinetics|March 17, 2005
Influence of itraconazole co-administration and CYP2D6 genotype on the pharmacokinetics of the new antipsychotic ARIPIPRAZOLEMasanori Kubo, Toshiko Koue, Atsuhiro Inaba, et al.Biochemical and Biophysical Research Communications|November 5, 2002
Identification of the novel splicing variants for the hPXR in human liversShuichi Fukuen, Tsuyoshi Fukuda, Hideyasu Matsuda, et al.Pharmacogenetics|June 4, 2002
Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese populationShuichi Fukuen, Tsuyoshi Fukuda, Hiromi Maune, et al.Drug Metabolism and Pharmacokinetics|April 28, 2005
The frequency of candidate alleles for CYP2D6 genotyping in the Japanese population with an additional respect to the -1584C to G substitutionYuka Ikenaga, Tsuyoshi Fukuda, Kazuhiro Fukuda, et al.Journal of Ethnopharmacology|September 20, 2011
Andrographolide inhibits the expression and metabolic activity of cytochrome P450 3A4 in the modified Caco-2 cellsFeng Qiu, Xiao-Long Hou, Kyoko Takahashi, et al.Pageof 13